FRAMINGHAM (02/26/2004) - Bristol-Myers Squibb Co. hopes to accelerate its research and drug discovery efforts with help from a newly purchased IBM Corp. supercomputer. The new system comprises 64 Advanced Micro Devices Inc. Opteron-based IBM eServer 325 systems. BMS says one reason for selecting the Opteron-based system was its ability to run both 32-bit and 64-bit Linux informatics applications.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.